Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | €59.00 | €75.80 | 28.475% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €76.00 | €79.00 | 3.947% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €224.30 | €247.61 | 10.391% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €189.40 | - | - |
| Lightpath Techs A | 3 | 0 | 0 | 0 | €1.35 | €2.78 | 106.193% |
| Cutera Inc. | 1 | 0 | 1 | 0 | €1.83 | €3.00 | 64.294% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.74 | €26.01 | 19.625% |
| Vitrolife AB | 3 | 0 | 0 | 0 | €14.10 | - | - |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €24.20 | €26.58 | 9.840% |
| Corcept Therapeutics Inc. | 8 | 0 | 1 | 0 | €22.02 | €33.55 | 52.346% |
| Neurocrine Bioscience | 21 | 0 | 1 | 0 | €136.05 | €137.10 | 0.772% |
| AnaptysBio Inc | 6 | 1 | 1 | 0 | €18.30 | €46.24 | 152.678% |
| Lemaitre Vascular Inc | 1 | 0 | 0 | 0 | €58.50 | - | - |
| ShockWave Medical Inc | 1 | 0 | 0 | 0 | €306.70 | - | - |
| X4 Pharmaceuticals, Inc. | 3 | 0 | 0 | 0 | €1.32 | €2.76 | 109.521% |
| Immunogen Inc. | 6 | 0 | 0 | 0 | €28.97 | - | - |
| Resmed Inc. | 16 | 0 | 2 | 0 | €171.10 | €189.13 | 10.539% |
| Integer Hldg | 1 | 0 | 0 | 0 | €109.00 | - | - |
| Rigel Pharmaceutical Inc. | 9 | 0 | 0 | 0 | €1.08 | €13.74 | 1171.249% |
| Actinium Pharmaceuticals Inc. | 3 | 0 | 1 | 0 | €6.83 | €8.50 | 24.542% |
| Tenet Healthcare | 23 | 0 | 3 | 0 | €89.00 | €95.79 | 7.634% |
| Savara Inc. | 1 | 0 | 1 | 0 | €4.42 | €8.00 | 80.995% |
| HCA Holdings Inc. | 19 | 0 | 2 | 0 | €297.90 | €289.63 | -2.777% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.39 | €55.00 | 4.982% |
| Henry Schein Inc. | 11 | 1 | 0 | 0 | €67.70 | €79.30 | 17.135% |